USPTO trademark

ORI

RegisteredUSPTOWord markClass 9Class 42

"ORI" is a word mark owned by Oribiotech Limited, filed at the USPTO on June 7, 2021. It is registered and covers classes 9 and 42.

Official USPTO record
ORI trademark as filed
As filed with the USPTO
Status
Registered
Since July 25, 2023
Filed
June 7, 2021
Registered
July 25, 2023
Priority date
June 1, 2021
Claimed from United Kingdom
Application no.
90757832
Registration no.
7117661
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns ORI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services ORI is filed for, grouped by Nice class.

  • downloadable computer software platforms for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy, and gene therapy; downloadable computer software platforms for monitoring environmental conditions within buildings, apparatuses and equipment, and for controlling, programming and adjusting devices within a building, facility, grounds, and designated spatial area that control environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; downloadable computer software platforms for collecting and storing data in the fields of cell culturing, cell therapy and gene therapy; downloadable computer software platforms for monitoring patient health, downloadable computer software platforms for providing information in the fields of cell culturing, cell therapy and gene therapy

  • Software as a service (SaaS) services featuring software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culture, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culture, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SAAS) services featuring software for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SAAS) services featuring software for collecting and storing of data in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring software for collecting and storing of data in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SaaS) services featuring software for monitoring patient health; Software as a service (SaaS) services featuring software for providing information in the fields of cell culture, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for providing information in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for providing information in the fields of cell culturing, cell therapy and gene therapy; design and development of scientific equipment and apparatus in the fields of cell culturing, cell therapy and gene therapy; design and development of cell culturing, cell therapy and gene therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; development of cell culturing, cell therapy and gene therapy processes for others; rental and leasing of scientific apparatus and equipment for cell culturing, cell therapy and gene therapy

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Teas change of domestic representatives address
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Teas change of correspondence received
  6. Teas change of domestic representatives address
  7. Attorney/dom.rep.revoked and/or appointed
  8. Teas revoke/app/change addr of atty/dom rep received
  9. Applicant/correspondence changes (non-responsive) entered
  10. Teas change of owner address received

10 earlier steps on the official record.

FAQ

About ORI

Who owns the trademark "ORI"?

The USPTO trademark "ORI" (application 90757832) is owned by Oribiotech Limited.

What is the status of "ORI"?

Its status at the USPTO is: registered.

When was "ORI" registered?

It was registered on July 25, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ORI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2d67-3949-7738-aa68-965d1ba2db2d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2d67-3949-7738-aa68-965d1ba2db2d",
  "object": "trademark",
  "mark_text": "ORI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90757832",
  "filing_date": "2021-06-07",
  "nice_classes": [
    9,
    42
  ],
  "owners": [
    {
      "name": "Oribiotech Limited",
      "entity_id": "ent_019eb70d-9fe3-736f-8562-592ee4425a64"
    }
  ]
}